Security key
94352A104
Wave Life Sciences, Inc. - Common Stock, $0.001 par value per share (WVE)
CUSIP: 94352A104
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 5,104
- Total 13F value
- $18,886
- Share change
- +5,104
- SEC-reported price per share
- $3.70
- Number of holders
- 4
- Value change
- +$18,886
- Number of buys
- 4
- Shares outstanding
- 204,252,417
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
4
Top holders
4
WVE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Wave Life Sciences, Inc. SEC filings
Wave Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 94352A104
Recent filing periods:
Ownership snapshot
Top reported holders of WVE - Wave Life Sciences, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
GSK plc
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 17%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
17%
BlackRock, Inc.
6.1%
MAVERICK CAPITAL LTD
5.4%
FMR LLC
2.8%
Adage Capital Management, L.P.
0.53%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
Company
|
17%
from 13D/G
|
$156,727,684
26,975,505 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$111,566,297
19,202,461 shares
|
— | 30 Jun 2026 |
| MAVERICK CAPITAL LTD |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$59,715,848
10,278,115 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13D/G
13F
Company
|
2.8%
|
$37,284,027
5,192,761 shares
|
-$70,566,627 | 31 Mar 2026 |
| Adage Capital Management, L.P. |
13D/G
|
0.53%
|
$7,180,000
1,000,000 shares
|
-$63,083,918 | 31 Mar 2026 |
| GSK plc |
3/4/5
13F
10%+ Owner · Company
|
9.7%
|
$346,668,129
18,245,691 shares
|
+$27,930,000 | 11 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
5,104
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
1
Q3 2026 holders
4
Holder diff
3
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend